ReP USP - Resultado da busca

Artigo de periodico
Sequesterpene lactones isolated from a Brazilian cerrado plant (Eremanthus spp.) as anti-proliferative compounds, characterized by functional and proteomic analysis, are candidates for new therapeutics in glioblastoma (2020)
Izumi, Clarice ; Laure, Helen Julie; Barbosa, Nayara Gonçalves; Thomé, Carolina Hassibe; Ferreira, Germano Aguiar ; Sousa, João Paulo Barreto de; Lopes, Norberto Peporine ; Rosa, José César
Source: International Journal of Molecular Sciences. Unidades: FMRP, FCFRP, EERP
Subjects: PRODUTOS NATURAIS, GLIOMA, BIOMARCADORES, NEOPLASIAS CEREBRAIS, COMPOSITAE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
IZUMI, Clarice et al. Sequesterpene lactones isolated from a Brazilian cerrado plant (Eremanthus spp.) as anti-proliferative compounds, characterized by functional and proteomic analysis, are candidates for new therapeutics in glioblastoma. International Journal of Molecular Sciences, v. 21, n. 13, p. 1-17, 2020Tradução . . Disponível em: https://doi.org/10.3390/ijms21134713. Acesso em: 04 nov. 2024.
APA
Izumi, C., Laure, H. J., Barbosa, N. G., Thomé, C. H., Ferreira, G. A., Sousa, J. P. B. de, et al. (2020). Sequesterpene lactones isolated from a Brazilian cerrado plant (Eremanthus spp.) as anti-proliferative compounds, characterized by functional and proteomic analysis, are candidates for new therapeutics in glioblastoma. International Journal of Molecular Sciences, 21( 13), 1-17. doi:10.3390/ijms21134713
NLM
Izumi C, Laure HJ, Barbosa NG, Thomé CH, Ferreira GA, Sousa JPB de, Lopes NP, Rosa JC. Sequesterpene lactones isolated from a Brazilian cerrado plant (Eremanthus spp.) as anti-proliferative compounds, characterized by functional and proteomic analysis, are candidates for new therapeutics in glioblastoma [Internet]. International Journal of Molecular Sciences. 2020 ; 21( 13): 1-17.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3390/ijms21134713
Vancouver
Izumi C, Laure HJ, Barbosa NG, Thomé CH, Ferreira GA, Sousa JPB de, Lopes NP, Rosa JC. Sequesterpene lactones isolated from a Brazilian cerrado plant (Eremanthus spp.) as anti-proliferative compounds, characterized by functional and proteomic analysis, are candidates for new therapeutics in glioblastoma [Internet]. International Journal of Molecular Sciences. 2020 ; 21( 13): 1-17.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3390/ijms21134713
Artigo de periodico
Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma (2015)
Gimenez, Marcela; Marie, Suely Kazue; Oba-Shinjo, Sueli; Uno, Miyuki; Izumi, Clarice; Oliveira, João Bosco; Rosa, Jose Cesar
Source: BMC Cancer. Unidades: FM, FMRP
Subjects: GLIOMA, NEOPLASIAS CEREBRAIS, SISTEMA NERVOSO CENTRAL, PROTEÍNAS (ESTUDO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIMENEZ, Marcela et al. Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma. BMC Cancer, v. 15, n. 481, p. (online), 2015Tradução . . Disponível em: https://doi.org/10.1186/s12885-015-1473-9. Acesso em: 04 nov. 2024.
APA
Gimenez, M., Marie, S. K., Oba-Shinjo, S., Uno, M., Izumi, C., Oliveira, J. B., & Rosa, J. C. (2015). Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma. BMC Cancer, 15( 481), (online). doi:10.1186/s12885-015-1473-9
NLM
Gimenez M, Marie SK, Oba-Shinjo S, Uno M, Izumi C, Oliveira JB, Rosa JC. Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma [Internet]. BMC Cancer. 2015 ; 15( 481): (online).[citado 2024 nov. 04 ] Available from: https://doi.org/10.1186/s12885-015-1473-9
Vancouver
Gimenez M, Marie SK, Oba-Shinjo S, Uno M, Izumi C, Oliveira JB, Rosa JC. Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma [Internet]. BMC Cancer. 2015 ; 15( 481): (online).[citado 2024 nov. 04 ] Available from: https://doi.org/10.1186/s12885-015-1473-9
Trabalho de evento-resumo periodico
Quantitative proteomic analysis reveals a molecular triad signature as biomarker candidates for astrocytomas and oligodendrogliomas (2013)
Rosa, José César; Marie, Suely Kazue Nagahashi; Oba-Shinjo, Sueli; Oliveira, João Bosco de; Otake, Andreia; Chammas, Roger; Izumi, Clarice; Ramão, Anelisa; Laure, Hélen Julie; Gimenez, Marcela
Source: Journal of the American Society for Mass Spectrometry. Conference titles: Conference on Mass Spectrometry and Allied Topics. Unidades: FM, FMRP
Subjects: GLIOMA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSA, José César et al. Quantitative proteomic analysis reveals a molecular triad signature as biomarker candidates for astrocytomas and oligodendrogliomas. Journal of the American Society for Mass Spectrometry. New York: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2013
APA
Rosa, J. C., Marie, S. K. N., Oba-Shinjo, S., Oliveira, J. B. de, Otake, A., Chammas, R., et al. (2013). Quantitative proteomic analysis reveals a molecular triad signature as biomarker candidates for astrocytomas and oligodendrogliomas. Journal of the American Society for Mass Spectrometry. New York: Faculdade de Medicina, Universidade de São Paulo.
NLM
Rosa JC, Marie SKN, Oba-Shinjo S, Oliveira JB de, Otake A, Chammas R, Izumi C, Ramão A, Laure HJ, Gimenez M. Quantitative proteomic analysis reveals a molecular triad signature as biomarker candidates for astrocytomas and oligodendrogliomas. Journal of the American Society for Mass Spectrometry. 2013 ; 24[citado 2024 nov. 04 ]
Vancouver
Rosa JC, Marie SKN, Oba-Shinjo S, Oliveira JB de, Otake A, Chammas R, Izumi C, Ramão A, Laure HJ, Gimenez M. Quantitative proteomic analysis reveals a molecular triad signature as biomarker candidates for astrocytomas and oligodendrogliomas. Journal of the American Society for Mass Spectrometry. 2013 ; 24[citado 2024 nov. 04 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em